Search

everythinglearnresearchcommunity

for

Search:↓

A woman developed severe skin damage after using a blood thinner called low-molecular-weight heparin.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.

Repigmentation in vitiligo may come from melanocyte stem cells in the skin.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

The document concludes that stem cells and their environments are crucial for skin and hair health and have potential for medical treatments.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

CGF therapy may help hair regrowth and improve scars in DLE patients.

3D-oxy exosomes may significantly boost hair growth, offering new treatment options for hair loss.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Finasteride may cause gum problems, but stopping the drug can improve these issues.

The patient's hair loss is most likely due to diffuse alopecia areata.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

Green tea component EGCG could potentially promote human hair growth.

New effective scar treatments are urgently needed due to the current options' limited success.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Transplant patients often get skin problems, with treatments varying by condition.

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.